Z-Lys(Ac)-NH2 is a protected lysine derivative presented as a Z (benzyloxycarbonyl/Cbz)-protected amino acid amide, featuring an ε-acetylated side chain on the lysine backbone. The molecule contains an N-terminal carbamate (Z-protecting group) and a carboxamide functionality at the C-terminus (−NH2), while the side chain retains the characteristic lysine carbon chain bearing an acetylated ε-amino group that reduces free amine reactivity. Z-Lys(Ac)-NH2 is used as a peptide synthesis building block or intermediate to control chemoselectivity by masking both the α-amino group and the ε-amino side chain, supporting stepwise assembly and subsequent deprotection strategies in chemical synthesis workflows.
CAT No: CP26798
CAS No:218938-54-6
Synonyms/Alias:Z-Nepsilon-acetyl-L-Lysineamide;benzylN-{1-[(1-carbamoylbutyl)carbamoyl]ethyl}carbamate;218938-54-6;NSC164075;AC1L6MZJ;AC1Q2UMB;CTK8E7584;MCULE-2795670966;NSC-164075;AM020315;RT-016317;benzylN-[1-[(1-amino-1-oxopentan-2-yl)amino]-1-oxopropan-2-yl]carbamate
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.